BNMS | AUTUMN
Light Medical, recently participated in the British Nuclear Medicine Meeting. Mark and Will attending the event held at 1 Wimpole Street the home of the Royal College of Medicine. At the event:
Cutting-Edge Technology: Light Medical showcased their latest shielding (syringe shields and vial shields), SPECT and PET sealed sources (Co-57, Ge-68, Cs-137), LIMS software, TLC and HPLC scanners, QC equipment. Setting new standards for accuracy and reducing radiation exposure, enhancing patient care.
Collaboration: They actively engaged with top companies and researchers to foster innovation and improve outcomes; ec² software solutions, Elysia-Raytest, Nuclear Shields, Epsilon (ERS), RadQual and Von Gahlen.
Key Takeaways:
Personalized Medicine: Nuclear medicine is moving towards personalized treatment plans and radionuclide therapy will play a huge part in that.
Reduced Radiation Exposure: Light Medical's innovative products prioritise user and patient safety with minimal radiation exposure.
Expanding Horizons: Ongoing work to improve market options for Nuclear Medicine, physics and radiopharamcy in the UK and Ireland.
In conclusion, a large delegate attendence at the British Nuclear Medicine Meeting reaffirms the commitment to driving nuclear medicine forward and improving patient care through cutting-edge technology and collaboration. The presence at the event signals strong support for the BNMS and the team are looking forward to Belfast 2024!